Problem

Attack Capital addresses the mismatch between traditional venture capital and the speed, technical complexity, and experimentation cycles of AI company creation. Founders often have a promising insight but still need to validate the problem, build an MVP, find initial customers, and become fundable; doing those steps sequentially is expensive and carries substantial product-market-fit and execution risk. The company’s central use case is an ambitious founder with a validated problem but no MVP, co-founder, or complete operating team who needs to turn that insight into a venture-scale AI company quickly.

It also addresses an access problem for investors: high-quality, early-stage AI and YC startups are difficult to source and evaluate before they enter mainstream VC pipelines. Attack Capital focuses on testing problem severity, willingness to pay, data availability, AI feasibility, and venture-scale potential, while giving accredited investors access to selected YC-backed opportunities. The economics are therefore built around reducing time-to-validation and founder risk, while improving access to early AI deal flow rather than waiting for companies to become established.

Product / Service

Attack Capital operates as an integrated AI venture studio and fund. For founders, it supplies a co-building team spanning product, design, engineering, go-to-market, and fundraising; the process runs from customer discovery and idea validation through prototype development, AI architecture, MVP launch, first customers, early revenue, and fundraising preparation. Its stated build cycle is 30 days, with up to $250,000 in initial studio funding, follow-on capital, and introductions to other venture funds. A founder can bring an idea without an MVP or co-founder, and if Attack Capital builds it, the founder earns equity.

For investors, the AI fund makes pre-seed and seed investments in YC companies and can provide follow-on support and co-investment access. Attack Capital says it invests directly in YC-backed AI startups and co-invests alongside firms such as Global Founders Capital and Slow Ventures. The combined model is intended to give founders capital and operating execution from day one, while giving investors a curated, AI-first pipeline with more technical and commercial validation than a passive investment model.

Market

Attack Capital competes at the intersection of AI venture studios, venture builders, early-stage venture capital, and startup-access platforms. Its investment focus includes vertical AI and SaaS, applied AI, agent workflows, robotics automation, cybersecurity, and infrastructure, with particular attention to industries such as healthcare, finance, legal, logistics, manufacturing, and enterprise operations. The clearest comparator is traditional VC: Attack Capital explicitly positions its studio as different because it builds from zero rather than investing only after a product exists. It also overlaps with accelerators and other venture studios, although its claimed differentiation is the combination of YC alumni access, an AI-only strategy, a 30-day build cycle, and a fund under the same platform.

The company reports that it built more than five AI startups in its first 24 months, with an average initial check size of $150,000 and a 100% YC-backed portfolio-access claim. Publicly identified investments include Andromeda Surgical, Electric Air, Baseplate, Hadrius, and Santé, while its site highlights HealOS as a studio portfolio company. Attack Capital is listed as founded in 2023 and active, but the available evidence does not disclose Attack Capital’s own revenue or establish that it is pre-revenue; its disclosures instead emphasize the substantial failure, traction, follow-on-financing, and illiquidity risks of early-stage and studio-built companies.